The electrostatic nature of C3d-complement receptor 2 association

Journal of Immunology

Volumn 172, Issue 12, 2004, Pages 7537-7547

  Morikis, Dimitrios ^a   Lambris, John D ^b  

^a University of California   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C3D RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CALCULATION; COMPLEX FORMATION; CONSENSUS SEQUENCE; CRYSTALLOGRAPHY; ELECTRIC POTENTIAL; IONIC STRENGTH; IONIZATION; MODEL; PH; PKA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

EID: 2942536153     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.12.7537     Document Type: Article

References (81)

1. Tsokos, G. C., J. D. Lambris, F. D. Finkelman, E. D. Anastassiou, and C. H. June. 1990. Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration. J. Immunol. 144:1640.
2. Fearon, D. T., and J. M. Ahearn. 1990. Complement receptor type 1 (C3/ C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21). Curr. Top. Microbiol. Immunol. 153:83.
3. Thyphronitis, G., T. Kinoshita, K. Inoue, J. E. Schweinle, G. C. Tsokos, E. S. Metcalf, F. D. Finkelman, and J. E. Barlow. 1991. Modulation of mouse complement receptor-1 and receptor-2 suppresses antibody responses in vivo. J. Immunol. 147:224.
4. Krych, M., J. P. Atkinson, and V. M. Holers. 1992. Complement receptors. Curr. Opin. Immunol. 4:8.
5. Tsoukas, C. D., and J. D. Lambris. 1993. Expression of EBV/C3d receptors on T cells: biological significance. Immunol. Today 14:56.
6. Carroll, M. C., and M. B. Fischer. 1997. Complement and the immune response. Curr. Opin. Immunol. 9:64.
7. Ahearn, J. A., and A. M. Rosengard. 1998. Complement receptors. In The Human Complement System in Health and Disease. J. E. Volanakis and M. Frank, eds. Marcel Dekker, New York, p. 167.
8. Carroll, M. C. 1998. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:545.
9. Tolnay, M., and G. C. Tsokos. 1998. Complement receptor 2 in regulation of the immune response. Clin. Immunol. Immunopathol. 88:123.
10. Fearon, D. T., and M. C. Carroll. 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18:393.
11. Barrington, R., M. Zhang, M. Fischer, and M. C. Carroll. 2001. The role of complement in inflammation and adaptive immunity. Immunol. Rev. 180:5.
12. Hannan, J., K. Young, G. Szakonyi, M. J. Overduin, S. J. Perkins, X. Chen, and V. M. Holers. 2002. Structure of complement receptor (CR) 2 and CR2-C3d complexes. Biochem. Soc. Trans. 30:983.
13. Lowell, C. A., L. B. Klickstein, R. H. Carter, J. A. Mitchell, D. T. Fearon, and J. M. Ahearn. 1989. Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2. J. Exp. Med. 170:1931.
14. Carel, J. C., B. L. Myones, B. Frazier, and V. M. Holers. 1990. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J. Biol. Chem. 265:12293.
15. Molina, H., C. Brenner, S. Jacobi, J. Gorka, J. C. Carel, T. Kinoshita, and V. M. Holers. 1991. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides: at least two distinct sites are necessary for ligand-receptor interaction. J. Biol. Chem. 266:12173.
16. Molina, H., S. J. Perkins, J. Guthridge, J. Gorka, T. Kinoshita, and V. M. Holers. 1995. Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3: an initial model of ligand interaction with two linked short consensus repeat modules. J. Immunol. 154:5426.
17. Aubry, J. P., S. Pochon, J. F. Gauchat, A. Nueda-Marin, V. M. Holers, P. Graber, C. Siegfried, and J. Y. Bonnefoy. 1994. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J. Immunol. 152:5806.
18. Prodinger, W. M., M. G. Schwendinger, J. Schoch, M. Kochle, C. Larcher, and M. P. Dierich. 1998. Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21). J. Immunol. 161:4604.
19. Szakonyi, G., J. M. Guthridge, D. Li, K. Young, V. M. Holers, and X. S. Chen. 2001. Structure of complement receptor 2 in complex with its C3d ligand. Science 292:1725.
20. Guthridge, J. M., J. K. Rakstang, K. A. Young, J. Hinshelwood, M. Aslam, A. Robertson, M. G. Gipson, M. R. Sarrias, W. T. Moore, M. Meagher, et al. 2001. Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/ CD21) and interactions with its ligand C3dg. Biochemistry 40:5931.
21. Guthridge, J. M., K. Young, M. G. Gipson, M. R. Sarrias, G. Szakonyi, X. S. Chen, A. Malaspina, E. Donoghue, J. A. James, J. D. Lambris, et al. 2001. Epitope mapping using the x-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface. J. Immunol. 167:5758.
22. Prota, A. E., D. R. Sage, T. Stehle, and J. D. Fingeroth. 2002. The crystal structure of human CD21: implications for Epstein-Barr virus and C3d binding. Proc. Natl. Acad. Sci. USA 99:10641.
23. Perkins, S. J., H. E. Gilbert, M. Aslam, J. Hannan, V. M. Holers, and T. H. J. Goodship. 2002. Solution structures of complement components by x-ray and neutron scattering and analytical ultracentrifugation. Biochem. Soc. Trans. 30:996.
24. Barlow, P. N., D. G. Norman, A. Steinkasserer, T. J. Horne, J. Pearce, P. C. Driscoll, R. B. Sim, and I. D. Campbell. 1992. Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. Biochemistry 31:3626.
25. Barlow, P. N., A. Steinkasserer, D. G. Norman, B. Kieffer, A. P. Wiles, R. B. Sim, and I. D. Campbell. 1993. Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol. 232:268.
26. Wiles, A. P., G. Shaw, J. Bright, A. Perczel, I. D. Campbell, and P. N. Barlow. 1997. NMR studies of a viral protein that mimics the regulators of complement activation. J. Mol. Biol. 272:253.
27. Casasnovas, J. M., M. Larvie, and T. Stehle. 1999. Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J. 18:2911.
28. Henderson, C. E., K. Bromek, N. P. Mullin, B. O. Smith, D. Uhrin, and P. N. Barlow. 2001. Solution structure and dynamics of the central CCP module pair of a poxvirus complement control protein. J. Mol. Biol. 307:323.
29. Murthy, K. H., S. A. Smith, V. K. Ganesh, K. W. Judge, N. Mullin, P. N. Barlow, C. M. Ogata, and G. J. Kotwal. 2001. Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans. Cell 104:301.
30. Herbert, A., J. O'Leary, M. Krych-Goldberg, J. P. Atkinson, and P. N. Barlow. 2002. Three-dimensional structure and flexibility of proteins of the RCA family-a progress report. Biochem. Soc. Trans. 30:990.
31. Smith, B. O., R. L. Mallin, M. Krych-Goldberg, X. Wang, R. E. Hauhart, K. Bromek, D. Uhrin, J. P. Atkinson, and P. N. Barlow. 2002. Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor. Cell 108:769.
32. Smith, S. A., G. Krishnasamy, K. H. Murthy, A. Cooper, K. Bromek, P. N. Barlow, and G. J. Kotwal. 2002. Vaccinia virus complement control protein is monomeric, and retains structural and functional integrity after exposure to adverse conditions. Biochim. Biophys. Acta 1598:55.
33. Moore, M. D., R. G. DiScipio, N. R. Cooper, and G. R. Nemerow. 1989. Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2). J. Biol. Chem. 264:20576.
34. Diefenbach, R. J., and D. E. Isenman. 1995. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2. J. Immunol. 154:2303.
35. Clemenza, L., and D. E. Isenman. 2000. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21). J. Immunol. 165:3839.
36. Sarrias, M. R., S. Franchini, G. Canziani, E. Argyropoulos, W. T. Moore, A. Sahu, and J. D. Lambris. 2001. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. J. Immunol. 167:1490.
37. Blom, A. M., J. Webb, B. O. Villoutreix, and B. Dahlback. 1999. A cluster of positively charged amino acids in the C4BP α-chain is crucial for C4b binding and factor I cofactor function. J. Biol. Chem. 274:19237.
38. Blom, A. M., K. Berggard, J. H. Webb, G. Lindahl, B. O. Villoutreix, and B. Dahlback. 2000. Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins. J. Immunol. 164:5328.
39. Nagar, B., R. G. Jones, R. J. Diefenbach, D. E. Isenman, and J. M. Rini. 1998. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 280:1277.
40. Honig, B., and A. Nicholls. 1995. Classical electrostatics in biology and chemistry. Science 268:1144.
41. Yang, A. S., and B. Honig. 1994. Structural origins of pH and ionic-strength effects of protein stability-acid denaturation of sperm whale apomyoglobin. J. Mol. Biol. 237:602.
42. Morikis, D., A. H. Elcock, P. A. Jennings, and J. A. McCammon. 2001. Native-state conformational dynamics of GART: a regulatory pH-dependent coil-helix transition examined by electrostatic calculations. Protein Sci. 10:2363.
43. Morikis, D., A. H. Elcock, P. A. Jennings, and J. A. McCammon. 2003. The pH dependence of stability of the activation helix and the catalytic site of GART. Biophys. Chem. 105:279.
44. Elcock, A. H., D. Sept, and J. A. McCammon. 2001. Computer simulation of protein-protein interactions. J. Phys. Chem. B. 105:1504.
45. Froloff, N., A. Windemuth, and B. Honig. 1997. On the calculation of binding free energies using continuum methods: application to MHC class I protein-peptide interactions. Protein Sci. 6:1293.
46. Gilson, M. K., T. P. Straatsma, J. A. McCammon, D. R. Ripoll, C. H. Faerman, P. H. Axelsen, I. Silman, and J. L. Sussman. 1994. Open back door in a molecular-dynamics simulation of acetylcholinesterase. Science 263:1276.
47. Morikis, D., A. H. Elcock, P. A. Jennings, and J. A. McCammon. 2001b. Proton transfer dynamics of GART: the pH-dependent catalytic mechanism examined by electrostatic calculations. Protein Sci. 10:2379.
48. Tanford, C., and J. G. Kirkwood. 1957. Theory of protein titration curves. I. General equations for impenetrable spheres. J. Am. Chem. Soc. 79:5333.
49. Tanford, C., and R. Roxby. 1972. Interpretation of protein titration curves: application to lysozyme. Biochemistry 11:2192.
50. Bashford, D., and M. Karplus. 1990. pKas of ionizable groups in proteins-atomic detail from a continuum electrostatic model. Biochemistry 44:10219.
51. Bashford, D., and M. Karplus. 1991. Multiple-site titration curves of proteins-an analysis of exact and approximate methods for their calculations. J. Phys. Chem. 95:9556.
52. Antosiewicz, J., J. A. McCammon, and M. K. Gilson. 1994. Prediction of pH-dependent properties of proteins. J. Mol. Biol. 238:415.
53. as in proteins. Biochemistry 35:7819.
54. Davis, M. E., J. D. Madura, B. A. Luty, and J. A. McCammon. 1991. Electrostatics and difussion of molecules in solution: simulations with the University of Houston Brownian dynamics program. Comp. Phys. Chem. 62:187.
55. Madura, J. D., M. E. Davis, M. K. Gilson, R. C. Wade, B. A. Luty, and J. A. McCammon. 1994. Biological applications of electrostatic calculations and Brownian dynamics simulations. Rev. Comput. Chem. 5:229.
56. Gilson, M. K. 1993. Multiple-site titration and molecular modelling: two rapid methods for computing energies and forces for ionizable groups in proteins. Proteins 15:266.
57. Sitkoff, D., K. A. Sharp, and B. Honig. 1994. Accurate calculation of hydration free energies using macroscopic solvent models. J. Phys. Chem. 98:1978.
58. Gilson, M. K., and B. Honig. 1988. Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins 4:7.
59. Gilson, M. K., and B. H. Honig. 1988. Energetics of charge-charge interactions in proteins. [Published erratum appears in 1992 Proteins 12:201.] Proteins 3:32.
60. Gilson, M. K., and B. H. Honig. 1988. Energetics of charge-charge interactions in proteins. [Published erratum appears in 1992 Proteins 12:201.] Proteins 3:32.
61. Davis, M. E., and J. A. McCammon. 1991. Dielectric boundary smoothing in finite difference solutions of the Poisson equation: an approach to improve accuracy and convergence. J. Comput. Chem. 12:909.
62. Elcock, A. H., and J. A. McCammon. 1998. Electrostatic contributions to the stability of halophilic proteins. J. Mol. Biol. 280:731.
63. Hasted, J. B., D. M. Ritson, and C. H. Collie. 1948. Dielectric properties of aqueous ionic solutions. Part I. J. Chem. Phys. 16:1.
64. Berman, H. M., J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235.
65. Vriend, G. 1990. WHAT IF: a molecular modeling and drug design program. J. Mol. Graphics 8:52.
66. Nielsen, J. E., K. V. Andersen, B. Honig, R. W. Hooft, G. Klebe, G. Vriend, and R. C. Wade. 1999. Improving macromolecular electrostatics calculations. Protein Eng. 12:657.
67. Hooft, R. W. W., C. Sander, and G. Vriend. 1996. Positioning hydrogen atoms by optimizing hydrogen-bond networks in protein structures. Proteins 26:363.
68. Koradi, R., M. Billeter, and K. Wuthrich. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics 14:51.
69. Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281.
70. Guex, N., and M. C. Peitsch. 1997. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714.
71. Norman, D. G., P. N. Barlow, M. Baron, A. J. Day, R. B. Sim, and I. D. Campbell. 1991. Three-dimensional structure of a complement control protein module in solution. J. Mol. Biol. 219:717.
72. Selzer, T., S. Albeck, and G. Schreiber. 2000. Rational design of faster and tighter binding protein complexes. Nat. Struct. Biol. 7:537.
73. Lambris, J. D., V. S. Ganu, S. Hirani, and H. J. Muller-Eberhard. 1985. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc. Natl. Acad. Sci. USA 82:4235.
74. Ullmann, G. M., and E. W. Knapp. 1999. Electrostatic models for computing protonation and redox equilibria in proteins. Eur. Biophys. J. 28:533.
75. Sheinerman, F. B., R. Norel, and B. Honig. 2000. Electrostatic aspects of protein-protein interactions. Curr. Opin. Struct. Biol. 10:153.
76. Simonson, T. 2001. Macromolecular electrostatics: continuum models and their growing pains. Curr. Opin. Struct. Biol. 11:243.
77. Baker, N. A., D. Sept, S. Joseph, M. J. Holst, and J. A. McCammon. 2001. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA 98:10037.
78. Elcock, A. H. 2002. Modeling supramolecular assemblages. Curr. Opin. Struct. Biol. 12:154.
79. Fogolari, F., A. Brigo, and H. Molinari. 2002. The Poisson-Boltzmann equation for biomolecular electrostatics: a tool for structural biology. J. Mol. Recognit. 15:377.
80. Simonson, T. 2003. Electrostatics and dynamics of proteins. Reports on Progress in Physics 66:737.
81. Morikis, D., M. Roy, M. G. Newlon, J. D. Scott, and P. A. Jennings. 2002. Electrostatic properties of the structure of the docking and dimerization domain of protein kinase A IIα. Eur. J. Biochem. 269:2040.